Trials / Completed
CompletedNCT05986201
Assessment of Long-term Effects of Tachosil
Assessment of Long-term Effects of Intraoperative Use of a Carrier-bound Fibrin Sealant (TachoSil®). We Had to Continue to Use it?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University of Catania · Academic / Other
- Sex
- All
- Age
- 32 Years – 87 Years
- Healthy volunteers
- —
Summary
This study aimed to analyse the long-term effects of a carrier-bound fibrin sealant (CBFS) after abdominal surgery by following up patients years after application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TachoSil® | TachoSil®, a carrier-bound fibrin sealant (CBFS), is a haemostatic tissue sealant composed of a collagen sponge, made from horse tendons, coated on one side with dried human fibrinogen and human thrombin. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2023-05-01
- Completion
- 2023-06-01
- First posted
- 2023-08-14
- Last updated
- 2023-08-14
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05986201. Inclusion in this directory is not an endorsement.